Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans

Blandine Patillon, Pierre Luisi, Hélène Blanché, Etienne Patin, Howard M Cann, Emmanuelle Génin, Audrey Sabbagh, Blandine Patillon, Pierre Luisi, Hélène Blanché, Etienne Patin, Howard M Cann, Emmanuelle Génin, Audrey Sabbagh

Abstract

VKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive selection in East Asian populations. In this study, we genotyped the HGDP-CEPH Panel for six VKORC1 SNPs and downloaded chromosome 16 genotypes from the HGDP-CEPH database in order to characterize the geographic distribution of footprints of positive selection within and around this locus. A unique VKORC1 haplotype carrying the promoter mutation associated with AVK sensitivity showed especially high frequencies in all the 17 HGDP-CEPH East Asian population samples. VKORC1 and 24 neighboring genes were found to lie in a 505 kb region of strong linkage disequilibrium in these populations. Patterns of allele frequency differentiation and haplotype structure suggest that this genomic region has been submitted to a near complete selective sweep in all East Asian populations and only in this geographic area. The most extreme scores of the different selection tests are found within a smaller 45 kb region that contains VKORC1 and three other genes (BCKDK, MYST1 (KAT8), and PRSS8) with different functions. Because of the strong linkage disequilibrium, it is not possible to determine if VKORC1 or one of the three other genes is the target of this strong positive selection that could explain present-day differences among human populations in AVK dose requirement. Our results show that the extended region surrounding a presumable single target of positive selection should be analyzed for genetic variation in a wide range of genetically diverse populations in order to account for other neighboring and confounding selective events and the hitchhiking effect.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Results of the VKORC1 haplotype…
Figure 1. Results of the VKORC1 haplotype study.
(A) Position of the seven SNPs along the VKORC1 gene.VKORC1 is a 4.1 kb gene (GenBank accession number AY587020) located at 16p11.2. The three exons of the gene are represented as boxes, with 5′UTR and 3′UTR regions colored in grey and coding regions in black. Flanking and intronic regions are represented as thin and thick lines, respectively. The seven studied SNPs are shown in their sequential order along the VKORC1 gene. The functional polymorphism rs9923231 located in the promoter, is highlighted in red and the SNP already present in the Illumina 650K chip in blue. Physical position along chromosome 16 is indicated in kb below. (B) Distribution of VKORC1 haplotypes at the global and regional level. For each haplotype, SNPs are listed in the same sequential order than in Figure 1A. Ancestral and derived alleles are shown in blue and orange, respectively. Haplotype labels H1 to H7 were given according to the global haplotype frequency. AF, sub-Saharan Africa; ME, Middle East; EUR, Europe; CSA, Central South Asia; EA, East Asia; OCE, Oceania; AM, America. (C) Median-joining network of the inferred VKORC1 haplotypes at the global level. Circles areas are proportional to the global haplotype frequency and branch lengths to the number of mutations separating haplotypes. Labels of haplotypes are indicated in corresponding circles, and labels of mutations on the network branches. The haplotype carrying the -1639A allele conferring the AVK sensitivity phenotype (H1) is shown in red and the ancestral haplotype (H6) in black.
Figure 2. Atypical patterns of genetic differentiation…
Figure 2. Atypical patterns of genetic differentiation observed for VKORC1 SNPs.
Genome-wide empirical distributions of FST values were constructed from 644,143 SNPs having a MAF ≥0.001 at the global level. Individual values of FST calculated for each of the seven VKORC1 SNPs are plotted against their global MAF. The functional rs9923231 SNP is shown in red. The 50th, 95th and 99th percentiles are indicated as dotted, dashed and full red lines, respectively.
Figure 3. Distribution of –log 10 (…
Figure 3. Distribution of –log10 (p-values) for four selection tests across a 2 Mb region centered on VKORC1.
A black vertical line indicates the physical position of VKORC1 on chromosome 16. Horizontal red dotted and dashed lines show 0.05 and 0.01 chromosome-wide significance levels, respectively. The selection tests (inter-regional FST, XP-CLR, XP-EHH and iHS, respectively) were separately applied in each of the seven geographic regions.
Figure 4. Detailed analysis of a 1.1…
Figure 4. Detailed analysis of a 1.1 Mb genomic region surrounding the VKORC1 gene locus in East Asia.
The boundaries of the region displayed (chr16:30,271,572-31,391,123; UCSC human genome build hg18) were chosen so as to include the three clusters of significant scores detected in East Asia by the selection tests in the 2 Mb region centered on VKORC1 (Figure 3). (A) Name and location of genes. Exons are displayed as blue boxes and the transcribed strand is indicated with an arrow. Genes located in the block of strong LD encompassing VKORC1 and including the SNPs in the red box shown in Figure 4C, are highlighted in the grey area. (B) XP-EHH results in East Asia. The significance of the XP-EHH scores (−log10 empirical p-value) are shown for individual SNPs with a MAF ≥0.01 in East Asia. Horizontal dashed lines indicate 0.05 and 0.01 chromosome-wide significance levels. Recombination hotspots detected in HapMap Phase II data are indicated by red vertical dotted lines. The data and methods used to derive these hotspots are available from the HapMap website (http://www.hapmap.org/) , . (C) LD plot. Pairwise LD values, depicted as D’, are shown for SNPs with a MAF ≥0.01 in East Asia. D’ values are displayed in different colors from yellow to red for D’ = 0 to D’ = 1, respectively. The red box highlights SNPs included in the LD block encompassing VKORC1. The plot was produced using the snp.plotter R package .

References

    1. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, et al. (1998) Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 114: 445S–469S.
    1. Hyers TM, Agnelli G, Hull RD, Weg JG, Morris TA, et al. (1998) Antithrombotic therapy for venous thromboembolic disease. Chest 114: 561S–578S.
    1. D'Andrea G, D'Ambrosio R, Margaglione M (2008) Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors. Blood Rev 22: 127–140.
    1. Cooper GM, Johnson JA, Langaee TY, Feng H, Stanaway IB, et al. (2008) A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood 112: 1022–1027.
    1. Takeuchi F, McGinnis R, Bourgeois S, Barnes C, Eriksson N, et al. (2009) A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet 5: e1000433.
    1. Teichert M, Eijgelsheim M, Rivadeneira F, Uitterlinden AG, van Schaik RH, et al. (2009) A genome-wide association study of acenocoumarol maintenance dosage. Hum Mol Genet 18: 3758–3768.
    1. Cha PC, Mushiroda T, Takahashi A, Kubo M, Minami S, et al. (2010) Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese. Hum Mol Genet 19: 4735–4744.
    1. Goldstein JA, de Morais SM (1994) Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4: 285–299.
    1. Stec DE, Roman RJ, Flasch A, Rieder MJ (2007) Functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics 30: 74–81.
    1. Bardowell SA, Stec DE, Parker RS (2010) Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity. J Nutr 140: 1901–1906.
    1. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, et al. (2004) Identification of the gene for vitamin K epoxide reductase. Nature 427: 541–544.
    1. Rost S, Fregin A, Ivaskevicius V, Conzelmann E, Hortnagel K, et al. (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427: 537–541.
    1. Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, et al. (2010) Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood 115: 3827–3834.
    1. Ross KA, Bigham AW, Edwards M, Gozdzik A, Suarez-Kurtz G, et al. (2010) Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements. J Hum Genet 55: 582–589.
    1. Li JZ, Absher DM, Tang H, Southwick AM, Casto AM, et al. (2008) Worldwide human relationships inferred from genome-wide patterns of variation. Science 319: 1100–1104.
    1. Shriver MD, Kennedy GC, Parra EJ, Lawson HA, Sonpar V, et al. (2004) The genomic distribution of population substructure in four populations using 8,525 autosomal SNPs. Hum Genomics 1: 274–286.
    1. Storz JF, Payseur BA, Nachman MW (2004) Genome scans of DNA variability in humans reveal evidence for selective sweeps outside of Africa. Mol Biol Evol 21: 1800–1811.
    1. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123: 585–595.
    1. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851–861.
    1. Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, et al. (2005) Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352: 2285–2293.
    1. Wu AH, Wang P, Smith A, Haller C, Drake K, et al. (2008) Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations. Pharmacogenomics 9: 169–178.
    1. Yang L, Ge W, Yu F, Zhu H (2010) Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement–a systematic review and meta analysis. Thromb Res 125: e159–166.
    1. Smith JM, Haigh J (1974) The hitch-hiking effect of a favourable gene. Genet Res 23: 23–35.
    1. Chen H, Patterson N, Reich D (2010) Population differentiation as a test for selective sweeps. Genome Res 20: 393–402.
    1. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, et al. (2002) Detecting recent positive selection in the human genome from haplotype structure. Nature 419: 832–837.
    1. Weir BS, Hill WG (2002) Estimating F-statistics. Annu Rev Genet 36: 721–750.
    1. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, et al. (2007) Genome-wide detection and characterization of positive selection in human populations. Nature 449: 913–918.
    1. Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) A map of recent positive selection in the human genome. PLoS Biol 4: e72.
    1. Clark AG, Hubisz MJ, Bustamante CD, Williamson SH, Nielsen R (2005) Ascertainment bias in studies of human genome-wide polymorphism. Genome Res 15: 1496–1502.
    1. Cann HM, de Toma C, Cazes L, Legrand MF, Morel V, et al. (2002) A human genome diversity cell line panel. Science 296: 261–262.
    1. Genin E, Tullio-Pelet A, Begeot F, Lyonnet S, Abel L (2004) Estimating the age of rare disease mutations: the example of Triple-A syndrome. J Med Genet 41: 445–449.
    1. Li J, Zhang L, Zhou H, Stoneking M, Tang K (2011) Global patterns of genetic diversity and signals of natural selection for human ADME genes. Hum Mol Genet 20: 528–540.
    1. Marsh S, King CR, Porche-Sorbet RM, Scott-Horton TJ, Eby CS (2006) Population variation in VKORC1 haplotype structure. J Thromb Haemost 4: 473–474.
    1. Limdi NA, Beasley TM, Crowley MR, Goldstein JA, Rieder MJ, et al. (2008) VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans. Pharmacogenomics 9: 1445–1458.
    1. Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, et al. (2008) Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 358: 999–1008.
    1. Geisen C, Watzka M, Sittinger K, Steffens M, Daugela L, et al. (2005) VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost 94: 773–779.
    1. Bodin L, Verstuyft C, Tregouet DA, Robert A, Dubert L, et al. (2005) Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. Blood 106: 135–140.
    1. Carlson CS, Thomas DJ, Eberle MA, Swanson JE, Livingston RJ, et al. (2005) Genomic regions exhibiting positive selection identified from dense genotype data. Genome Res 15: 1553–1565.
    1. Wang ET, Kodama G, Baldi P, Moyzis RK (2006) Global landscape of recent inferred Darwinian selection for Homo sapiens. Proc Natl Acad Sci U S A 103: 135–140.
    1. Teo YY, Sim X, Ong RT, Tan AK, Chen J, et al. (2009) Singapore Genome Variation Project: a haplotype map of three Southeast Asian populations. Genome Res 19: 2154–2162.
    1. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L (2008) Natural selection has driven population differentiation in modern humans. Nat Genet 40: 340–345.
    1. Akey JM (2009) Constructing genomic maps of positive selection in humans: where do we go from here? Genome Res 19: 711–722.
    1. Xue Y, Zhang X, Huang N, Daly A, Gillson CJ, et al. (2009) Population differentiation as an indicator of recent positive selection in humans: an empirical evaluation. Genetics 183: 1065–1077.
    1. Hofer T, Ray N, Wegmann D, Excoffier L (2009) Large allele frequency differences between human continental groups are more likely to have occurred by drift during range expansions than by selection. Ann Hum Genet 73: 95–108.
    1. Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, et al. (2009) Signals of recent positive selection in a worldwide sample of human populations. Genome Res 19: 826–837.
    1. Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, et al. (2008) A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 40: 152–154.
    1. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358: 900–909.
    1. Jarvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Panelius J, et al. (2010) Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus. PLoS One 5: e14212.
    1. Scheinfeldt LB, Biswas S, Madeoy J, Connelly CF, Akey JM (2011) Clusters of adaptive evolution in the human genome. Front Genet 2: 50.
    1. Barreiro LB, Quintana-Murci L (2010) From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 11: 17–30.
    1. Suttie JW (1985) Vitamin K-dependent carboxylase. Annu Rev Biochem 54: 459–477.
    1. Oldenburg J, Marinova M, Muller-Reible C, Watzka M (2008) The vitamin K cycle. Vitam Horm 78: 35–62.
    1. Yan L, Zhou B, Greenberg D, Wang L, Nigdikar S, et al. (2004) Vitamin K status of older individuals in northern China is superior to that of older individuals in the UK. Br J Nutr 92: 939–945.
    1. Beavan SR, Prentice A, Stirling DM, Dibba B, Yan L, et al. (2005) Ethnic differences in osteocalcin gamma-carboxylation, plasma phylloquinone (vitamin K1) and apolipoprotein E genotype. Eur J Clin Nutr 59: 72–81.
    1. Kaneki M, Hodges SJ, Hosoi T, Fujiwara S, Lyons A, et al. (2001) Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 17: 315–321.
    1. Fujita Y, Iki M, Tamaki J, Kouda K, Yura A, et al.. (2011) Association between vitamin K intake from fermented soybeans, natto, and bone mineral density in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int.
    1. Vermeer C, Shearer MJ, Zittermann A, Bolton-Smith C, Szulc P, et al. (2004) Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 43: 325–335.
    1. Wardrop D, Keeling D (2008) The story of the discovery of heparin and warfarin. Br J Haematol 141: 757–763.
    1. Mueller RL, Scheidt S (1994) History of drugs for thrombotic disease. Discovery, development, and directions for the future. Circulation 89: 432–449.
    1. Kohn MH, Pelz HJ, Wayne RK (2000) Natural selection mapping of the warfarin-resistance gene. Proc Natl Acad Sci U S A 97: 7911–7915.
    1. Kohn MH, Pelz HJ, Wayne RK (2003) Locus-specific genetic differentiation at Rw among warfarin-resistant rat (Rattus norvegicus) populations. Genetics 164: 1055–1070.
    1. Diaz JC, Song Y, Moore A, Borchert JN, Kohn MH (2010) Analysis of vkorc1 polymorphisms in Norway rats using the roof rat as outgroup. BMC Genet 11: 43.
    1. Song Y, Endepols S, Klemann N, Richter D, Matuschka FR, et al. (2011) Adaptive introgression of anticoagulant rodent poison resistance by hybridization between old world mice. Curr Biol 21: 1296–1301.
    1. Hernandez RD, Kelley JL, Elyashiv E, Melton SC, Auton A, et al. (2011) Classic selective sweeps were rare in recent human evolution. Science 331: 920–924.
    1. Pritchard JK, Di Rienzo A (2010) Adaptation - not by sweeps alone. Nat Rev Genet 11: 665–667.
    1. Pritchard JK, Pickrell JK, Coop G (2010) The genetics of human adaptation: hard sweeps, soft sweeps, and polygenic adaptation. Curr Biol 20: R208–215.
    1. Coop G, Pickrell JK, Novembre J, Kudaravalli S, Li J, et al. (2009) The role of geography in human adaptation. PLoS Genet 5: e1000500.
    1. Consortium TGP (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061–1073.
    1. Cann HM (1998) Human genome diversity. C R Acad Sci III 321: 443–446.
    1. Rosenberg NA (2006) Standardized subsets of the HGDP-CEPH Human Genome Diversity Cell Line Panel, accounting for atypical and duplicated samples and pairs of close relatives. Ann Hum Genet 70: 841–847.
    1. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162–1169.
    1. Bandelt HJ, Forster P, Rohl A (1999) Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16: 37–48.
    1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
    1. Luna A, Nicodemus KK (2007) snp.plotter: an R-based SNP/haplotype association and linkage disequilibrium plotting package. Bioinformatics 23: 774–776.
    1. Lewontin RC (1964) The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models. Genetics 49: 49–67.
    1. Hill WG, Robertson A (1968) Linkage disequilibrium in finite populations Theoretical and Applied Genetics. 38: 226–231.
    1. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, et al. (2006) Positive natural selection in the human lineage. Science 312: 1614–1620.
    1. Wright S (1951) The genetical structure of populations. Annals of Eugenics 15 323–354.
    1. Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, et al. (2002) The Bioperl toolkit: Perl modules for the life sciences. Genome Res 12: 1611–1618.
    1. Beaumont MA, Nichols RA (1996) Evaluating loci for use in the genetic analysis of population structure. The Royal Society 263: 1619–1626.
    1. Gardner M, Bertranpetit J, Comas D (2008) Worldwide genetic variation in dopamine and serotonin pathway genes: implications for association studies. Am J Med Genet B Neuropsychiatr Genet 147B: 1070–1075.
    1. Scheet P, Stephens M (2006) A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78: 629–644.
    1. McVean GA, Myers SR, Hunt S, Deloukas P, Bentley DR, et al. (2004) The fine-scale structure of recombination rate variation in the human genome. Science 304: 581–584.
    1. Winckler W, Myers SR, Richter DJ, Onofrio RC, McDonald GJ, et al. (2005) Comparison of fine-scale recombination rates in humans and chimpanzees. Science 308: 107–111.

Source: PubMed

3
Abonneren